PEAK6 Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-21,200
Closed -$575K 5099
2021
Q2
$575K Sell
21,200
-14,400
-40% -$352K ﹤0.01% 3097
2021
Q1
$833K Buy
35,600
+27,900
+362% +$564K ﹤0.01% 2730
2020
Q4
$118K Sell
7,700
-20,400
-73% -$259K ﹤0.01% 3975
2020
Q3
$339K Hold
28,100
﹤0.01% 3137
2020
Q2
$286K Buy
+28,100
New +$290K ﹤0.01% 3126
2019
Q1
Sell
-14,300
Closed -$288K 3774
2018
Q4
$288K Hold
14,300
﹤0.01% 2770
2018
Q3
$311K Buy
+14,300
New +$318K ﹤0.01% 2919

Other funds holding ANGO

PEAK6 Investments's ANGO Position: Q3 2021 in Review

PEAK6 Investments sold out of AngioDynamics (ANGO) in Q3 2021, closing a stake of 68 shares — an estimated $2K sold.

PEAK6 Investments first reported a position in ANGO in Q3 2018 and held it in 5 quarters. The position peaked at $157K in Q4 2018. 156 funds tracked by Wall St. Rank hold ANGO as of Q3 2021.

  • PEAK6 Investments reported no remaining AngioDynamics position as of Q3 2021 after selling out during the quarter.
  • PEAK6 Investments sold 68 AngioDynamics shares in Q3 2021, an estimated $2K.
  • PEAK6 Investments first reported a position in AngioDynamics in Q3 2018 and held it in 5 quarters.
  • PEAK6 Investments's AngioDynamics position peaked at $157K in Q4 2018.
  • 156 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2021.

Based on PEAK6 Investments's 13F filing for Q3 2021, filed 12 Nov 2021.